For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...

Def Leppard played their first concert of 2025 without guitarist Vivian Campbell, who was absent due to cancer treatment, in ...

Campbell, the guitarist for Def Leppard, made headlines this week because he missed the band’s first show of 2025 which took ...

Vivian Campbell has missed both shows Def Leppard have played since the finish of last year's Summer Stadium Tour ...

Def Leppard guitarist Vivian Campbell missed the band's first concert of 2025 due to his recovery from cancer treatment.

Updated overall survival data from KEYNOTE-564 showed adjuvant pembrolizumab benefits in clear cell renal cell carcinoma, but some patients remain unresponsive.

Bicycle Therapeutics (BCYC) announced updated topline Phase 1 combination data for zelenectide pevedotin plus pembrolizumab in previously ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

First-line pembrolizumab “has consistent antitumor activity and safety” in patients with advanced urothelial carcinoma who are potentially ineligible for platinum‐based chemotherapy, researchers found ...

(RTTNews) - Bicycle Therapeutics plc (BCYC), Monday announced updated topline Phase 1 combination data for zelenectide pevedotin plus pembrolizumab in previously untreated (first-line) ...

Merck (MRK) stock in focus as the company eyes 2025 launch of subcutaneous Keytruda amid a looming patent cliff for its ...

(Pembrolizumab + vibostolimab) is under clinical development by Merck and currently in Phase II for Metastatic Colorectal Cancer.